394 related articles for article (PubMed ID: 26497546)
21. Volumetric magnetic resonance imaging analysis in patients with short-term remission of Cushing's disease.
Jiang H; Ren J; He NY; Liu C; Sun YH; Jian FF; Bian LG; Shen JK; Yan FH; Pan SJ; Sun QF
Clin Endocrinol (Oxf); 2017 Oct; 87(4):367-374. PubMed ID: 28543178
[TBL] [Abstract][Full Text] [Related]
22. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
23. Past adult lead exposure is linked to neurodegeneration measured by brain MRI.
Stewart WF; Schwartz BS; Davatzikos C; Shen D; Liu D; Wu X; Todd AC; Shi W; Bassett S; Youssem D
Neurology; 2006 May; 66(10):1476-84. PubMed ID: 16717205
[TBL] [Abstract][Full Text] [Related]
24. [Correlation between cognitive function and hippocampal atrophy and cerebral white matter lesions in patients with obstructive sleep apnea hypopnea syndrome].
Peng W; Chen R; Jiang Z; Xu X; Wang J; Li J; Liu C
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):724-8. PubMed ID: 24844952
[TBL] [Abstract][Full Text] [Related]
25. How early can one diagnose Cushing's disease? An early diagnosis in a case of prepubertal Cushing's disease.
Hoppmann J; Wagner IV; Junghans G; Wudy SA; Buchfelder M; Hirsch FW; Ritter L; Kiess W; Pfäffle R
J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1043-7. PubMed ID: 25367688
[TBL] [Abstract][Full Text] [Related]
26. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes.
Manschot SM; Biessels GJ; de Valk H; Algra A; Rutten GE; van der Grond J; Kappelle LJ;
Diabetologia; 2007 Nov; 50(11):2388-97. PubMed ID: 17764005
[TBL] [Abstract][Full Text] [Related]
27. Surgical remission of Cushing's syndrome reduces cardiovascular risk.
Terzolo M; Allasino B; Pia A; Peraga G; Daffara F; Laino F; Ardito A; Termine A; Paccotti P; Berchialla P; Migliaretti G; Reimondo G
Eur J Endocrinol; 2014 Jul; 171(1):127-36. PubMed ID: 24801586
[TBL] [Abstract][Full Text] [Related]
28. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines.
Mancini T; Kola B; Mantero F; Boscaro M; Arnaldi G
Clin Endocrinol (Oxf); 2004 Dec; 61(6):768-77. PubMed ID: 15579193
[TBL] [Abstract][Full Text] [Related]
29. The association of regional white matter lesions with cognition in a community-based cohort of older individuals.
Jiang J; Paradise M; Liu T; Armstrong NJ; Zhu W; Kochan NA; Brodaty H; Sachdev PS; Wen W
Neuroimage Clin; 2018; 19():14-21. PubMed ID: 30034997
[TBL] [Abstract][Full Text] [Related]
30. Cerebral white matter lesions in patients with dementia - from MCI to severe Alzheimer's disease.
Targosz-Gajniak M; Siuda J; Ochudło S; Opala G
J Neurol Sci; 2009 Aug; 283(1-2):79-82. PubMed ID: 19268974
[TBL] [Abstract][Full Text] [Related]
31. Detrimental effects of hypercortisolism on brain structure and related risk factors.
Chen Y; Zhang J; Tan H; Li J; Yu Y
Sci Rep; 2020 Jul; 10(1):12708. PubMed ID: 32728036
[TBL] [Abstract][Full Text] [Related]
32. Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profile.
Dovio A; Allasino B; Palmas E; Ventura M; Pia A; Saba L; Aroasio E; Terzolo M; Angeli A
J Clin Endocrinol Metab; 2007 May; 92(5):1803-8. PubMed ID: 17327380
[TBL] [Abstract][Full Text] [Related]
33. Structural MRI substrates of cognitive impairment in neuromyelitis optica.
Liu Y; Fu Y; Schoonheim MM; Zhang N; Fan M; Su L; Shen Y; Yan Y; Yang L; Wang Q; Zhang N; Yu C; Barkhof F; Shi FD
Neurology; 2015 Oct; 85(17):1491-9. PubMed ID: 26423432
[TBL] [Abstract][Full Text] [Related]
34. Ambulatory blood pressure as an independent determinant of brain atrophy and cognitive function in elderly hypertension.
Nagai M; Hoshide S; Ishikawa J; Shimada K; Kario K
J Hypertens; 2008 Aug; 26(8):1636-41. PubMed ID: 18622243
[TBL] [Abstract][Full Text] [Related]
35. The structural and functional consequences of diurnal variations in blood pressure in treated patients with hypertensive cerebrovascular disease.
Birns J; Morris R; Jarosz J; Markus H; Kalra L
J Hypertens; 2009 May; 27(5):1042-8. PubMed ID: 19337131
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission.
Faggiano A; Pivonello R; Spiezia S; De Martino MC; Filippella M; Di Somma C; Lombardi G; Colao A
J Clin Endocrinol Metab; 2003 Jun; 88(6):2527-33. PubMed ID: 12788849
[TBL] [Abstract][Full Text] [Related]
37. Personality characteristics and quality of life in patients treated for Cushing's syndrome.
Sonino N; Bonnini S; Fallo F; Boscaro M; Fava GA
Clin Endocrinol (Oxf); 2006 Mar; 64(3):314-8. PubMed ID: 16487442
[TBL] [Abstract][Full Text] [Related]
38. High blood pressure and cerebral white matter lesion progression in the general population.
Verhaaren BF; Vernooij MW; de Boer R; Hofman A; Niessen WJ; van der Lugt A; Ikram MA
Hypertension; 2013 Jun; 61(6):1354-9. PubMed ID: 23529163
[TBL] [Abstract][Full Text] [Related]
39. Excessive lowering of blood pressure is not beneficial for progression of brain white matter hyperintensive and cognitive impairment in elderly hypertensive patients: 4-year follow-up study.
Peng J; Lu F; Wang Z; Zhong M; Sun L; Hu N; Liu Z; Zhang W
J Am Med Dir Assoc; 2014 Dec; 15(12):904-10. PubMed ID: 25239015
[TBL] [Abstract][Full Text] [Related]
40. White matter lesions as a feature of cognitive impairment, low vitality and other symptoms of geriatric syndrome in the elderly.
Sonohara K; Kozaki K; Akishita M; Nagai K; Hasegawa H; Kuzuya M; Yokote K; Toba K
Geriatr Gerontol Int; 2008 Jun; 8(2):93-100. PubMed ID: 18713161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
